126 related articles for article (PubMed ID: 32681952)
21. TAT-apoptin is efficiently delivered and induces apoptosis in cancer cells.
Guelen L; Paterson H; Gäken J; Meyers M; Farzaneh F; Tavassoli M
Oncogene; 2004 Feb; 23(5):1153-65. PubMed ID: 14691460
[TBL] [Abstract][Full Text] [Related]
22. HSPA9 overexpression inhibits apoptin-induced apoptosis in the HepG2 cell line.
Peng C; Yang P; Cui Y; He M; Liang L; Di Y
Oncol Rep; 2013 Jun; 29(6):2431-7. PubMed ID: 23589050
[TBL] [Abstract][Full Text] [Related]
23. Apoptin acts as a tumor-specific killer: potentials for an anti-tumor therapy.
Noteborn MH
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(1):49-60. PubMed ID: 16171564
[TBL] [Abstract][Full Text] [Related]
24. Apoptin, A Versatile Protein with Selective Antitumor Activity.
Castro J; Ribo M; Benito A; Vilanova M
Curr Med Chem; 2018; 25(30):3540-3559. PubMed ID: 29521208
[TBL] [Abstract][Full Text] [Related]
25. Design, expression, and renaturation of a lesion-targeted recombinant epidermal growth factor-von Willebrand factor fusion protein: efficacy in an animal model of experimental colitis.
Hall FL; Kaiser A; Liu L; Chen ZH; Hu J; Nimni ME; Beart RW; Gordon EM
Int J Mol Med; 2000 Dec; 6(6):635-43. PubMed ID: 11078822
[TBL] [Abstract][Full Text] [Related]
26. Anti-neoplastic effect of chicken anemia virus VP3 protein (apoptin) in Rous sarcoma virus-induced tumours in chicken.
Natesan S; Kataria JM; Dhama K; Bhardwaj N; Sylvester A
J Gen Virol; 2006 Oct; 87(Pt 10):2933-2940. PubMed ID: 16963752
[TBL] [Abstract][Full Text] [Related]
27. Apoptin towards safe and efficient anticancer therapies.
Backendorf C; Noteborn MH
Adv Exp Med Biol; 2014; 818():39-59. PubMed ID: 25001531
[TBL] [Abstract][Full Text] [Related]
28. Genetically engineered and self-assembled oncolytic protein nanoparticles for targeted cancer therapy.
Lee JJ; Kang JA; Ryu Y; Han SS; Nam YR; Rho JK; Choi DS; Kang SW; Lee DE; Kim HS
Biomaterials; 2017 Mar; 120():22-31. PubMed ID: 28024232
[TBL] [Abstract][Full Text] [Related]
29. PTD4-apoptin protein therapy inhibits tumor growth in vivo.
Sun J; Yan Y; Wang XT; Liu XW; Peng DJ; Wang M; Tian J; Zong YQ; Zhang YH; Noteborn MH; Qu S
Int J Cancer; 2009 Jun; 124(12):2973-81. PubMed ID: 19326452
[TBL] [Abstract][Full Text] [Related]
30. Human Gyrovirus Apoptin shows a similar subcellular distribution pattern and apoptosis induction as the chicken anaemia virus derived VP3/Apoptin.
Bullenkamp J; Cole D; Malik F; Alkhatabi H; Kulasekararaj A; Odell EW; Farzaneh F; Gäken J; Tavassoli M
Cell Death Dis; 2012 Apr; 3(4):e296. PubMed ID: 22495351
[TBL] [Abstract][Full Text] [Related]
31. Systemic delivery of lentivirus-mediated secretable TAT-apoptin eradicates hepatocellular carcinoma xenografts in nude mice.
Ma JL; Han SX; Zhao J; Zhang D; Wang L; Li YD; Zhu Q
Int J Oncol; 2012 Sep; 41(3):1013-20. PubMed ID: 22767069
[TBL] [Abstract][Full Text] [Related]
32. A peptide derived from apoptin inhibits glioma growth.
Zhang L; Zhao H; Cui Z; Lv Y; Zhang W; Ma X; Zhang J; Sun B; Zhou D; Yuan L
Oncotarget; 2017 May; 8(19):31119-31132. PubMed ID: 28415709
[TBL] [Abstract][Full Text] [Related]
33. A bispecific fusion protein and a bifunctional enediyne-energized fusion protein consisting of TRAIL, EGFR peptide ligand, and apoprotein of lidamycin against EGFR and DR4/5 show potent antitumor activity.
Zhu D; Wang X; Shang Y; Li Y; Jiang W; Li L; Chen SZ
Anticancer Drugs; 2015 Jan; 26(1):64-73. PubMed ID: 25122444
[TBL] [Abstract][Full Text] [Related]
34. Cloning and expression of a novel target fusion protein and its application in anti-tumor therapy.
Sun R; Zhu Y; Feng H; Yang Z; Bian X; Gu P; Wang C; Liu Y
Cell Physiol Biochem; 2015; 35(5):1877-91. PubMed ID: 25871436
[TBL] [Abstract][Full Text] [Related]
35. [Molecular mechanism of specific induction of apoptosis in tumor cells by apoptin].
Wang QM; He FC
Ai Zheng; 2005 Apr; 24(4):509-12. PubMed ID: 15820081
[TBL] [Abstract][Full Text] [Related]
36. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin.
Sachdev D; Chirgwin JM
Protein Expr Purif; 1998 Feb; 12(1):122-32. PubMed ID: 9473466
[TBL] [Abstract][Full Text] [Related]
37. Production of a human epidermal growth factor fusion protein and its degradation in rat gastrointestinal flushings.
Xian CJ; Upton Z; Goddard C; Shoubridge CA; McNeil KA; Wallace JC; Read LC; Francis GL
J Mol Endocrinol; 1996 Feb; 16(1):89-97. PubMed ID: 8672237
[TBL] [Abstract][Full Text] [Related]
38. Enhanced expression of apoptin by the Myc-Max binding motif and SV40 enhancer for SCLC gene therapy.
Song JS
Biosci Biotechnol Biochem; 2005 Jan; 69(1):51-5. PubMed ID: 15665467
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of a recombinant pseudotype baculovirus expressing Apoptin in vitro and in vivo.
Pan Y; Fang L; Fan H; Luo R; Zhao Q; Chen H; Xiao S
Int J Cancer; 2010 Jun; 126(11):2741-51. PubMed ID: 19824041
[TBL] [Abstract][Full Text] [Related]
40. Targeting the epidermal growth factor receptor in breast cancer cell lines with a recombinant ligand fusion toxin (DAB389EGF).
Osborne CK; Coronado-Heinsohn E
Cancer J Sci Am; 1996; 2(3):175-80. PubMed ID: 9166518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
